Prosecution Insights
Last updated: August 06, 2026

Arentfox Schiff LLP And Cardinal Health

10 pending office actions • 3 clients • 9 examiners • 6 art units • 0 of 10 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days

Quality Metrics (n=33105 apps, methodology: how we score firms)

88.1%
Allowance Rate
n=33105
+0.53σ
Allowance Rate (norm)
n=33105
3.3
OAs to Allowance
n=22173
-0.12σ
OAs to Allow (norm)
n=22173
1015 days
Time to Allowance
n=22173
+7.4pp
Interview Lift
n=33105
28.9%
RCE Rate
n=33105
1.4%
Appeal Rate
n=33105

Rejection Performance (% of received rejections ultimately overcome)

81.6%
§101 Overcome
n=3320
80.4%
§102 Overcome
n=9027
80.9%
§103 Overcome
n=14466
81.1%
§112 Overcome
n=8656

Specialization & Scale

H04L, H04W, G06F
Top CPC Subclasses
17%
Top-3 CPC Share
n=33105
20
Practitioners
n=33105
1655.2
Apps / Practitioner
n=33105

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (40%)
5
Medium (50%)
0
Easy (0%)
1
Unknown (10%)

Rejection Statute Mix

BucketCases
§103 only4 (40%)
Double-patenting + other1 (10%)
Multi-statute (no §101)4 (40%)
No statute on record1 (10%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
10% of docket
2
Mechanical / Eng
20% of docket
2
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LAU, JONATHAN S 2 64.0% -18.2%
RUSHING, MARK S 1 76.7% +24.3%
KIM, AHSHIK 1 88.1% +10.2%
SHOULDERS, ANNIE LEE 1 73.4% +18.5%
BROWN, KYLE MARTZ 1 9.4% +4.2%
ZAMORY, JUSTIN L 1 72.7% +17.4%
HANDY, DWAYNE K 1 62.7% +24.9%
VU, JAKE MINH 1 40.6% +27.4%
SAMALA, JAGADISHWAR RAO 1 67.9% +55.5%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18189658 Competitive Self-Blocking with Unlabeled Manocept Imaging Agents VU, JAKE MINH 12d
18641038 ELECTRODE CONNECTOR WITH MOTION ARTIFACT DAMPENER BROWN, KYLE MARTZ 41d
18351905 MANNOSYLATED AMINE DEXTRAN DRUG DELIVERY VEHICLES WITH DEGRADABLE DISULFIDE/CARBONATE LINKERS TARGETING PAYLOADS TO CD206 EXPRESSING CELLS LAU, JONATHAN S 83d
18962578 ECG ELECTRODE WITH RETENTION FEATURE SHOULDERS, ANNIE LEE

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
19229159 METHODS AND SYSTEMS FOR MANAGING INVENTORY THROUGH THE SUPPLY CHAIN AND LIFECYCLE OF A PRODUCT KIM, AHSHIK 8d overdue
18189658 Competitive Self-Blocking with Unlabeled Manocept Imaging Agents VU, JAKE MINH 12d
19233942 REMOTE MONITORING OF ABSORBENT ARTICLE RUSHING, MARK S
18962578 ECG ELECTRODE WITH RETENTION FEATURE SHOULDERS, ANNIE LEE
18623418 CASSETTE FOR A FLOW CONTROL APPARATUS ZAMORY, JUSTIN L
18408350 SYSTEMS, METHODS AND DEVICES FOR PRODUCING, MANUFACTURING AND CONTROL OF RADIOPHARMACEUTICALS HANDY, DWAYNE K
17131087 COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME SAMALA, JAGADISHWAR RAO

Client Portfolio (3 clients)

Client (Assignee)Pending OAs
Cardinal Health 5
KPR U.S. 4
WAVEMARK, INC. 1

Top Art Units

Art UnitApps
16932
16182
28761
37941
37831
17981

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19233942 REMOTE MONITORING OF ABSORBENT ARTICLE Kpr U.S., LLC RUSHING, MARK S §103 Non-Final OA Pending Jun 10, 2025
19229159 METHODS AND SYSTEMS FOR MANAGING INVENTORY THROUGH THE SUPPLY CHAIN AND LIFECYCLE OF A PRODUCT Wavemark, Inc. KIM, AHSHIK 2876 Other Final Rejection 8d overdue Pending Jun 05, 2025
18962578 ECG ELECTRODE WITH RETENTION FEATURE Kpr U.S., LLC SHOULDERS, ANNIE LEE §102§103 Non-Final OA Pending Nov 27, 2024
18641038 ELECTRODE CONNECTOR WITH MOTION ARTIFACT DAMPENER Kpr U.S., LLC BROWN, KYLE MARTZ 3794 §102§103 Non-Final OA 41d Pending Apr 19, 2024
18623418 CASSETTE FOR A FLOW CONTROL APPARATUS Kpr U.S., LLC ZAMORY, JUSTIN L 3783 §112DP Non-Final OA Pending Apr 01, 2024
18408350 SYSTEMS, METHODS AND DEVICES FOR PRODUCING, MANUFACTURING AND CONTROL OF RADIOPHARMACEUTICALS Cardinal Health 414, LLC HANDY, DWAYNE K 1798 §103 Final Rejection Pending Jan 09, 2024
18351905 MANNOSYLATED AMINE DEXTRAN DRUG DELIVERY VEHICLES WITH DEGRADABLE DISULFIDE/CARBONATE LINKERS TARGETING PAYLOADS TO CD206 EXPRESSING CELLS Cardinal Health 414, LLC LAU, JONATHAN S 1693 §102§103 Non-Final OA 83d Pending Jul 13, 2023
18189658 Competitive Self-Blocking with Unlabeled Manocept Imaging Agents Cardinal Health 414, LLC VU, JAKE MINH 1618 §103§112 Non-Final OA 12d Pending Mar 24, 2023
18148023 METHODS FOR THE CONJUGATION OF ANTHRACYCLINES TO CARBOHYDRATE POLYMERIC CARRIERS Cardinal Health 414, LLC LAU, JONATHAN S 1693 §103Other Non-Final OA 28d overdue Pending Dec 29, 2022
17131087 COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME Cardinal Health 414, LLC SAMALA, JAGADISHWAR RAO 1618 §103 Final Rejection Pending Dec 22, 2020

Managing Arentfox Schiff LLP And Cardinal Health's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month